Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $43.0K — — — — — — —
Accounts Receivable $48.0K $107.3K $1.1K $19.9K — — — —
Inventory $0 $119.6K $9.9K $1.6K — — — —
Total Current Assets $106.3K $281.1K $37.3K $151.0K $10.9K — — —
Property, Plant & Equipment $5.8K $53.4K $27.6K $1.6K — — — —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $117.0K $376.8K $69.9K $152.6K $10.9K $32.5K $18.6K $20.8K
Liabilities
Accounts Payable $476.8K $592.2K $248.8K $105.3K $1.9K $21.1K $18.6K $7.5K
Total Current Liabilities $1.3M $3.9M $853.0K — $63.2K $21.1K $18.6K $7.5K
Long-Term Debt $0 — — — — — — —
Total Liabilities $1.4M $3.9M $853.0K $139.7K $63.2K $21.1K $18.6K $7.5K
Stockholders' Equity
Retained Earnings $-14.5M $-11.1M $-2.1M $-860.4K $-122.1K $-56.2K $-24.1K $-11.7K
Total Stockholders' Equity $-1.3M $-3.6M $-783.1K $12.8K $-52.3K $11.3K $-61 $13.3K
← Newer Page 2 of 2 Older →